Syndeio Biosciences, Inc

This study tested whether a single dose of the experimental drug zelquistinel (AGN-241751) can quickly improve depression symptoms compared to a placebo. 251 adults with major depressive disorder took either the drug or a dummy pill, and researchers measured mood changes using a …

This study tested an experimental drug called AGN-241751 in 226 adults with major depressive disorder. Participants received either the drug or a placebo to see if it could quickly improve depression symptoms. The trial was completed and aimed to measure changes in mood using a s…

This early-stage trial tested the safety of a single dose of zelquistinel, an experimental drug for major depressive disorder, in 68 healthy adults. Researchers monitored side effects and how the drug moves through the body. Since it was a Phase 1 study, it focused on safety and …